Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
Ana Claudia Cavalcante NogueiraJoaquim BarretoFilipe A MouraBeatriz LuchiariAbrão AbuhabIsabella BonilhaWilson NadruzJ Michael GazianoThomas GazianoLuiz Sergio F de CarvalhoAndrei Carvalho Spositonull nullPublished in: Health economics review (2023)
CRD42020194415.